In conjunction with the present data, an earlier report demonstrated the anti-obesity effects of CAV1, as evidenced by reduced Cav1 expression in visceral adipose tissue of obese patients [10]. The gene discussed is CAV1; the disease is obesity due to melanocortin 4 receptor deficiency.